Cytokinetics Inc (CYTK)
59.53
-0.39
(-0.65%)
USD |
NASDAQ |
May 17, 16:00
59.57
+0.04
(+0.07%)
After-Hours: 20:00
Cytokinetics Gross Profit (TTM): -328.52M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -328.52M |
| December 31, 2023 | -322.59M |
| September 30, 2023 | -312.35M |
| June 30, 2023 | -290.42M |
| March 31, 2023 | -176.25M |
| December 31, 2022 | -146.22M |
| September 30, 2022 | -61.06M |
| June 30, 2022 | -43.84M |
| March 31, 2022 | -109.28M |
| December 31, 2021 | -89.51M |
| September 30, 2021 | -124.11M |
| June 30, 2021 | -63.63M |
| March 31, 2021 | -48.22M |
| December 31, 2020 | -41.12M |
| September 30, 2020 | -31.75M |
| June 30, 2020 | -63.41M |
| March 31, 2020 | -62.09M |
| December 31, 2019 | -59.26M |
| September 30, 2019 | -60.04M |
| June 30, 2019 | -56.61M |
| March 31, 2019 | -55.10M |
| December 31, 2018 | -56.88M |
| September 30, 2018 | -69.25M |
| June 30, 2018 | -77.27M |
| March 31, 2018 | -78.66M |
| Date | Value |
|---|---|
| December 31, 2017 | -76.93M |
| September 30, 2017 | -36.30M |
| June 30, 2017 | 23.65M |
| March 31, 2017 | 36.49M |
| December 31, 2016 | 46.51M |
| September 30, 2016 | 28.66M |
| June 30, 2016 | -16.14M |
| March 31, 2016 | -18.31M |
| December 31, 2015 | -17.74M |
| September 30, 2015 | -1.269M |
| June 30, 2015 | 0.338M |
| March 31, 2015 | 2.483M |
| December 31, 2014 | 2.514M |
| September 30, 2014 | 0.06M |
| June 30, 2014 | -6.911M |
| March 31, 2014 | -14.30M |
| December 31, 2013 | -18.80M |
| September 30, 2013 | -37.00M |
| June 30, 2013 | -35.11M |
| March 31, 2013 | -30.17M |
| December 31, 2012 | -28.08M |
| September 30, 2012 | -56.84M |
| June 30, 2012 | -48.32M |
| March 31, 2012 | -40.87M |
| December 31, 2011 | -33.18M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
-328.52M
Minimum
Mar 2024
-31.75M
Maximum
Sep 2020
-124.51M
Average
-63.52M
Median
Gross Profit (TTM) Benchmarks
| Amgen Inc | 19.60B |
| Johnson & Johnson | 61.53B |
| Viking Therapeutics Inc | -- |
| Eli Lilly and Co | 28.80B |
| Madrigal Pharmaceuticals Inc | -- |